Therefore, we propose that in addition to the described function of silencing B cell differentiation genes59, EZH2 gain-of-function mutations may also activate an MLL–MEN1-dependent oncogenic gene expression program to facilitate DLBCL pathogenesis (Fig. 5h). This evidence concerns the gene KMT2A and diffuse large B-cell lymphoma.